Abstract
Considerable evidence is accumulating about the regulatory function of coding- and non-coding RNAs through chemical modifications on their own nitrogen bases. The mechanisms by which the amount and types of these modifications are built to each type of RNA are yet poorly clarified, although some classes of proteins have been identified as actors able to introduce (writers), specifically recognize (readers) or delate (erasers) such modifications. In this context, advances have been made thanks to bioinformatic tools, which have allowed a comprehensive database, where RNA processing and post-transcriptional modification are integrated and elucidated, to be generated. Now, it is accepted that the abovementioned epitranscriptome interplay is involved in orchestrating development, health, and disease, also including the development, function, and dysfunction of the nervous system. In this chapter, we aim at reviewing and describing the potential mechanisms associated with the dysregulation of the epitranscriptome and neuropathologies, focusing specifically on brain cancer and neurodegenerative disorders.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alvarez-Dominguez JR, Lodish HF (2017) Emerging mechanisms of long noncoding RNA function during normal and malignant hematopoiesis. Blood 130:1965–1975
Alzheimer’s Association (2020) Alzheimer’s disease facts and figures. Alzheimers Dement. https://doi.org/10.1002/alz.12068
Amlie-Wolf A, Tang M, Way J et al (2019) Inferring the molecular mechanisms of noncoding Alzheimer’s disease-associated genetic variants. J Alzheimers Dis 72:301–318
An H, Williams NG, Shelkovnikova TA (2018) NEAT1 and paraspeckles in neurodegenerative diseases: A missing lnc found? Noncoding RNA Res 3:243–252
Angelbello AJ, Chen JL, Disney MD (2020) Small molecule targeting of RNA structures in neurological disorders. Ann NY Acad Sci 1471:57–71
Angelova MT, Dimitrova DG, Dinges N et al (2018) The emerging field of epitranscriptomics in neurodevelopmental and neuronal disorders. Front Bioeng Biotechnol 6:46
Arena A, Iyer AM, Milenkovic I et al (2017) Developmental expression and dysregulation of miR-146a and miR-155 in Down’s syndrome and mouse models of Down’s syndrome and Alzheimer’s disease. Curr Alzheimer Res 14:1305–1317
Argentati C, Tortorella I, Bazzucchi M et al (2020) The other side of Alzheimer’s disease: influence of metabolic disorder features for novel diagnostic biomarkers. J Pers Med 10:115
Armstrong RA (2019) Risk factors for Alzheimer’s disease. Folia Neuropathol 57:87–105
Asano K, Suzuki T, Saito A et al (2018) Metabolic and chemical regulation of tRNA modification associated with taurine deficiency and human disease. Nucleic Acids Res 46:1565–1583
Bagyinszky E, Giau VV, An SA (2020) Transcriptomics in Alzheimer’s disease: aspects and challenges. Int J Mol Sci 21. https://doi.org/10.3390/ijms21103517
Balestrino R, Schapira AHV (2020) Parkinson disease. Eur J Neurol 27:27–42
Banelli B, Forlani A, Allemanni G et al (2017) MicroRNA in glioblastoma: an overview. Int J Genomics 2017:7639084
Barbagallo D, Condorelli A, Ragusa M et al (2016) Dysregulated miR-671-5p / CDR1-AS / CDR1 / VSNL1 axis is involved in glioblastoma multiforme. Oncotarget 7:4746–4759
Barbagallo D, Caponnetto A, Cirnigliaro M et al (2018) CircSMARCA5 inhibits migration of glioblastoma multiforme cells by regulating a molecular axis involving splicing factors SRSF1/SRSF3/PTB. Int J Mol Sci 19:480
Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20:303–322
Bassi S, Tripathi T, Monziani A et al (2017) Epigenetics of Huntington’s disease. Adv Exp Med Biol 978:277–299
Bennett SA, Tanaz R, Cobos SN et al (2019) Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease. Transl Res 204:19–30
Bertram L, Tanzi RE (2019) Alzheimer disease risk genes: 29 and counting. Nat Rev Neurol 15:191–192
Biamonti G, Amato A, Belloni E et al (2019) Alternative splicing in Alzheimer’s disease. Aging Clin Exp Res. https://doi.org/10.1007/s40520-019-01360-x
Bicchi I, Morena F, Montesano S et al (2013) MicroRNAs and molecular mechanisms of neurodegeneration. Genes (Basel) 4:244–263
Boccaletto P, Machnicka MA, Purta E et al (2018) MODOMICS: a database of RNA modification pathways. 2017 update. Nucleic Acids Res 46:D303–D307
Bogomazova AN, Eremeev AV, Pozmogova GE et al (2019) The role of mutant RNA in the pathogenesis of Huntington’s disease and other polyglutamine diseases. Mol Biol (Mosk) 53:954–967
Bohnsack MT, Sloan KE (2018) The mitochondrial epitranscriptome: the roles of RNA modifications in mitochondrial translation and human disease. Cell Mol Life Sci 75:241–260
Botti V, Cesaretti A, Ban Ž et al (2019) Fine structural tuning of styryl-based dyes for fluorescence and CD-based sensing of various ds-DNA/RNA sequences. Org Biomol Chem 17:8243–8258
Botti V, Urbanelli L, Sagini K et al (2020) Quaternized styryl-azinium fluorophores as cellular RNA-binders. Photochem Photobiol Sci 19:362–370
Braggin JE, Bucks SA, Course MM et al (2019) Alternative splicing in a presenilin 2 variant associated with Alzheimer disease. Ann Clin Transl Neurol 6:762–777
Briggs JA, Wolvetang EJ, Mattick JS et al (2015) Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution. Neuron 88:861–877
Brodie S, Lee HK, Jiang W et al (2017) The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells. Oncotarget 8:31785–31801
Bucha S, Mukhopadhyay D, Bhattacharyya NP (2015) Regulation of mitochondrial morphology and cell cycle by microRNA-214 targeting Mitofusin2. Biochem Biophys Res Commun 465:797–802
Burk K, Pasterkamp RJ (2019) Disrupted neuronal trafficking in amyotrophic lateral sclerosis. Acta Neuropathol 137:859–877
Butti Z, Patten SA (2018) RNA dysregulation in amyotrophic lateral sclerosis. Front Genet 9:712
Cai H, Liu X, Zheng J et al (2017) Long non-coding RNA taurine upregulated 1 enhances tumor-induced angiogenesis through inhibiting microRNA-299 in human glioblastoma. Oncogene 36:318–331
Calzoni E, Cesaretti A, Polchi A et al (2019) Biocompatible polymer nanoparticles for drug delivery applications in cancer and neurodegenerative disorder therapies. J Funct Biomater 10:4
Campos-Melo D, Droppelmann CA, He Z et al (2013) Altered microRNA expression profile in amyotrophic lateral sclerosis: a role in the regulation of NFL mRNA levels. Mol Brain 6:26
Cao M, Li H, Zhao J et al (2019) Identification of age- and gender-associated long noncoding RNAs in the human brain with Alzheimer’s disease. Neurobiol Aging 81:116–126
Catanesi M, d’Angelo M, Tupone MG et al (2020) MicroRNAs dysregulation and mitochondrial dysfunction in neurodegenerative diseases. Int J Mol Sci 21:5986
Ceyzériat K, Zilli T, Millet P et al (2020) Learning from the past: a review of clinical trials targeting amyloid, tau and neuroinflammation in Alzheimer’s disease. Curr Alzheimer Res 17:112–125
Chanda K, Das S, Chakraborty J et al (2018) Altered levels of long NcRNAs Meg3 and Neat1 in cell and animal models of Huntington’s disease. RNA Biol 15:1348–1363
Chen X-Q, Mobley WC (2019) Alzheimer disease pathogenesis: insights from molecular and cellular biology studies of oligomeric Aβ and Tau species. Front Neurosci 13:659
Chen G, Wang Z, Wang D et al (2013) LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res 41:D983–D986
Chen Y, Lian Y-J, Ma Y-Q et al (2018) LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells. Neurotoxicology 68:212–221
Chen F-Z, Zhao Y, Chen H-Z (2019a) MicroRNA-98 reduces amyloid β-protein production and improves oxidative stress and mitochondrial dysfunction through the Notch signaling pathway via HEY2 in Alzheimer’s disease mice. Int J Mol Med 43:91–102
Chen X, Yu C, Guo M et al (2019b) Down-regulation of m6A mRNA methylation is involved in dopaminergic neuronal death. ACS Chem Neurosci 10:2355–2363
Cheng C, Spengler RM, Keiser MS et al (2018) The long non-coding RNA NEAT1 is elevated in polyglutamine repeat expansion diseases and protects from disease gene-dependent toxicities. Hum Mol Genet 27:4303–4314
Chia R, Chiò A, Traynor BJ (2018) Novel genes associated with amyotrophic lateral sclerosis: diagnostic and clinical implications. Lancet Neurol 17:94–102
Cho HJ, Liu G, Jin SM et al (2013) MicroRNA-205 regulates the expression of Parkinson’s disease-related leucine-rich repeat kinase 2 protein. Hum Mol Genet 22:608–620
Cui Q, Shi H, Ye P et al (2017) m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells. Cell Rep 18:2622–2634
Dahariya S, Paddibhatla I, Kumar S et al (2019) Long non-coding RNA: classification, biogenesis and functions in blood cells. Mol Immunol 112:82–92
Dai D, Wang H, Zhu L et al (2018) N6-methyladenosine links RNA metabolism to cancer progression. Cell Death Dis 9:124
Das U, Wang L, Ganguly A et al (2016) Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway. Nat Neurosci 19:55–64
Dash D, Mestre TA (2020) Therapeutic update on Huntington’s disease: symptomatic treatments and emerging disease-modifying therapies. Neurotherapeutics. https://doi.org/10.1007/s13311-020-00891-w
De Felice B, Manfellotto F, Fiorentino G et al (2018) Wide-ranging analysis of microRNA profiles in sporadic amyotrophic lateral sclerosis using next-generation sequencing. Front Genet 9:310
Delaidelli A, Jan A, Herms J et al (2019) Translational control in brain pathologies: biological significance and therapeutic opportunities. Acta Neuropathol 137:535–555
DeVos SL, Miller RL, Schoch KM et al (2017) Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci Transl Med 9:eaag0481
Dolinar A, Koritnik B, Glavač D et al (2019) Circular RNAs as potential blood biomarkers in amyotrophic lateral sclerosis. Mol Neurobiol 56:8052–8062
Dong Z, Cui H (2020) The emerging roles of RNA modifications in glioblastoma. Cancers (Basel) 12:736
Dorszewska J, Prendecki M, Oczkowska A et al (2016) Molecular basis of familial and sporadic Alzheimer’s disease. Curr Alzheimer Res 13:952–963
Dube U, Del-Aguila JL, Li Z et al (2019) An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nat Neurosci 22:1903–1912
Dykes IM, Emanueli C (2017) Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genomics Proteomics Bioinformatics 15:177–186
Eom GH, Kim K-B, Kim JH et al (2011) Histone methyltransferase SETD3 regulates muscle differentiation. J Biol Chem 286:34733–34742
Essack M, Salhi A, Van Neste C et al (2020) DES-ROD: exploring literature to develop new links between RNA oxidation and human diseases. Oxid Med Cell Longev 2020:5904315
Esteller M (2011) Non-coding RNAs in human disease. Nat Rev Genet 12:861–874
Esteve-Puig R, Bueno-Costa A, Esteller M (2020) Writers, readers and erasers of RNA modifications in cancer. Cancer Lett 474:127–137
Faghihi MA, Modarresi F, Khalil AM et al (2008) Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nat Med 14:723–730
Faghihi MA, Zhang M, Huang J et al (2010) Evidence for natural antisense transcript-mediated inhibition of microRNA function. Genome Biol 11:R56
Fan W, Liang C, Ou M et al (2020) MicroRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases. Front Mol Neurosci 13:90
Fang M, Wang J, Zhang X et al (2012) The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer’s disease. Toxicol Lett 209:94–105
Farr SA, Ripley JL, Sultana R et al (2014) Antisense oligonucleotide against GSK-3β in brain of SAMP8 mice improves learning and memory and decreases oxidative stress: involvement of transcription factor Nrf2 and implications for Alzheimer disease. Free Radic Biol Med 67:387–395
Fernandes JCR, Acuña SM, Aoki JI et al (2019) Long non-coding RNAs in the regulation of gene expression: physiology and disease. Noncoding RNA 5:17
Ferrante M, Conti GO (2017) Environment and neurodegenerative diseases: an update on miRNA role. Microrna 6:157–165
Fisher AJ, Beal PA (2018) Structural basis for eukaryotic mRNA modification. Curr Opin Struct Biol 53:59–68
Flamand MN, Meyer KD (2019) The epitranscriptome and synaptic plasticity. Curr Opin Neurobiol 59:41–48
Fotuhi SN, Khalaj-Kondori M, Hoseinpour Feizi MA et al (2019) Long non-coding RNA BACE1-AS may serve as an Alzheimer’s disease blood-based biomarker. J Mol Neurosci 69:351–359
Fransquet PD, Ryan J (2018) Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer’s disease. Clin Biochem 58:5–14
Fusilli C, Migliore S, Mazza T et al (2018) Biological and clinical manifestations of juvenile Huntington’s disease: a retrospective analysis. Lancet Neurol 17:986–993
Gagliardi D, Dziembowski A (2018) 5’ and 3’ modifications controlling RNA degradation: from safeguards to executioners. Philos Trans R Soc Lond B Biol Sci 373:20180160
Gagliardi S, Zucca S, Pandini C et al (2018) Long non-coding and coding RNAs characterization in peripheral blood mononuclear cells and spinal cord from amyotrophic lateral sclerosis patients. Sci Rep 8:2378
Galardi S, Michienzi A, Ciafrè SA (2020) Insights into the regulatory role of m6A epitranscriptome in glioblastoma. Int J Mol Sci 21:2816
Garcia HG, Berrocal A, Kim YJ et al (2020) Lighting up the central dogma for predictive developmental biology. Curr Top Dev Biol 137:1–35
Garcia-Manteiga JM, D’Alessandro R, Meldolesi J (2019) News about the role of the transcription factor REST in neurons: from physiology to pathology. Int J Mol Sci 21:235
Ge J, Yu Y-T (2013) RNA pseudouridylation: new insights into an old modification. Trends Biochem Sci 38:210–218
Ge B, Li S-L, Li F-R (2020) Astragaloside-IV regulates endoplasmic reticulum stress-mediated neuronal apoptosis in a murine model of Parkinson’s disease via the lincRNA-p21/CHOP pathway. Exp Mol Pathol 115:104478
Geng L, Zhang T, Liu W et al (2018) Inhibition of miR-128 abates Aβ-mediated cytotoxicity by targeting PPAR-γ via NF-κB inactivation in primary mouse cortical neurons and Neuro2a cells. Yonsei Med J 59:1096–1106
Ghosh A, Mizuno K, Tiwari SS et al (2020) Alzheimer’s disease-related dysregulation of mRNA translation causes key pathological features with ageing. Transl Psychiatry 10:192
Gillies GE, Pienaar IS, Vohra S et al (2014) Sex differences in Parkinson’s disease. Front Neuroendocrinol 35:370–384
Ginns EI, Mak SK-K, Ko N et al (2014) Neuroinflammation and α-synuclein accumulation in response to glucocerebrosidase deficiency are accompanied by synaptic dysfunction. Mol Genet Metab 111:152–162
Gu C, Chen C, Wu R et al (2018) Long noncoding RNA EBF3-AS promotes neuron apoptosis in Alzheimer’s disease. DNA Cell Biol 37:220–226
Guo R, Fan G, Zhang J et al (2017) A 9-microRNA signature in serum serves as a noninvasive biomarker in early diagnosis of Alzheimer’s disease. J Alzheimers Dis 60:1365–1377
Guo T, Zhang D, Zeng Y et al (2020) Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease. Mol Neurodegener 15:40
Han S, Miller JE, Byun S et al (2019) Identification of exon skipping events associated with Alzheimer’s disease in the human hippocampus. BMC Med Genomics 12:13
Han M, Liu Z, Xu Y et al (2020) Abnormality of m6A mRNA methylation is involved in Alzheimer’s disease. Front Neurosci 14:98
Hanan M, Simchovitz A, Yayon N et al (2020) A Parkinson’s disease CircRNAs resource reveals a link between circSLC8A1 and oxidative stress. EMBO Mol Med 12:e11942
Hartford CCR, Lal A (2020) When long noncoding becomes protein coding. Mol Cell Biol 40:e00528–e00519
Hébert SS, Horré K, Nicolaï L et al (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc Natl Acad Sci USA 105:6415–6420
Helm M, Motorin Y (2017) Detecting RNA modifications in the epitranscriptome: predict and validate. Nat Rev Genet 18:275–291
Höglinger GU, Michel PP, Champy P et al (2005) Experimental evidence for a toxic etiology of tropical parkinsonism. Mov Disord 20:118–119
Hon C-C, Ramilowski JA, Harshbarger J et al (2017) An atlas of human long non-coding RNAs with accurate 5’ ends. Nature 543:199–204
Hsu PJ, Shi H, He C (2017) Epitranscriptomic influences on development and disease. Genome Biol 18:197
Hu S, Wang H, Chen K et al (2015) MicroRNA-34c downregulation ameliorates amyloid-β-induced synaptic failure and memory deficits by targeting VAMP2. J Alzheimers Dis 48:673–686
Huang T, Chen W, Liu J et al (2019a) Genome-wide identification of mRNA 5-methylcytosine in mammals. Nat Struct Mol Biol 26:380–388
Huang Z, Shi J, Gao Y et al (2019b) HMDD v3.0: a database for experimentally supported human microRNA-disease associations. Nucleic Acids Res 47:D1013–D1017
Huang AZ, Delaidelli A, Sorensen PH (2020a) RNA modifications in brain tumorigenesis. Acta Neuropathol Commun 8:64
Huang H, Camats-Perna J, Medeiros R et al (2020b) Altered expression of the m6A methyltransferase METTL3 in Alzheimer’s disease. eNeuro 7:ENEURO.0125-20.2020
Jacob R, Zander S, Gutschner T (2017) The dark side of the epitranscriptome: chemical modifications in long non-coding RNAs. Int J Mol Sci 18:2387
Jain G, Stuendl A, Rao P et al (2019) A combined miRNA-piRNA signature to detect Alzheimer’s disease. Transl Psychiatry 9:250
Jakubauskienė E, Vilys L, Pečiulienė I et al (2020) The role of hypoxia on Alzheimer’s disease-related APP and Tau mRNA formation. Gene 766:145146
Janin M, Ortiz-Barahona V, de Moura MC et al (2019) Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational program. Acta Neuropathol 138:1053–1074
Jiang Q, Shan K, Qun-Wang X et al (2016a) Long non-coding RNA-MIAT promotes neurovascular remodeling in the eye and brain. Oncotarget 7:49688–49698
Jiang X, Yan Y, Hu M et al (2016b) Increased level of H19 long noncoding RNA promotes invasion, angiogenesis, and stemness of glioblastoma cells. J Neurosurg 124:129–136
Jin Y, Tu Q, Liu M (2018) MicroRNA-125b regulates Alzheimer’s disease through SphK1 regulation. Mol Med Rep 18:2373–2380
John A, Kubosumi A, Reddy PH (2020) Mitochondrial microRNAs in aging and neurodegenerative diseases. Cells 9:1345
Jonkhout N, Tran J, Smith MA et al (2017) The RNA modification landscape in human disease. RNA 23:1754–1769
Jovicic A, Zaldivar Jolissaint JF, Moser R et al (2013) MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington’s disease-related mechanisms. PLoS One 8:e54222
Jung Y, Goldman D (2018) Role of RNA modifications in brain and behavior. Genes Brain Behav 17:e12444
Juźwik CA, Drake S, Zhang Y et al (2019) microRNA dysregulation in neurodegenerative diseases: a systematic review. Prog Neurobiol 182:101664
Kawarada L, Suzuki T, Ohira T et al (2017) ALKBH1 is an RNA dioxygenase responsible for cytoplasmic and mitochondrial tRNA modifications. Nucleic Acids Res 45:7401–7415
Kenny A, Jiménez-Mateos EM, Zea-Sevilla MA et al (2019) Proteins and microRNAs are differentially expressed in tear fluid from patients with Alzheimer’s disease. Sci Rep 9:15437
Kilchert C, Sträßer K, Kunetsky V et al (2020) From parts lists to functional significance-RNA-protein interactions in gene regulation. Wiley Interdiscip Rev RNA 11:e1582
Kim W, Lee Y, McKenna ND et al (2014) miR-126 contributes to Parkinson’s disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling. Neurobiol Aging 35:1712–1721
Kirchner S, Ignatova Z (2015) Emerging roles of tRNA in adaptive translation, signalling dynamics and disease. Nat Rev Genet 16:98–112
Kong Y, Wu J, Zhang D et al (2015) The role of miR-124 in drosophila Alzheimer’s disease model by targeting delta in notch signaling pathway. Curr Mol Med 15:980–989
Kong B, Wu P-C, Chen L et al (2016) microRNA-7 protects against 1-methyl-4-phenylpyridinium iodide-induced cell apoptosis in SH-SY5Y cells by directly targeting Krüpple-like factor 4. DNA Cell Biol 35:217–225
Kraus TFJ, Haider M, Spanner J et al (2017) Altered long noncoding RNA expression precedes the course of Parkinson’s disease-a preliminary report. Mol Neurobiol 54:2869–2877
Kumar A, Kumar V, Singh K et al (2020) Therapeutic advances for Huntington’s disease. Brain Sci 10:43
Lafontaine DLJ (2015) Noncoding RNAs in eukaryotic ribosome biogenesis and function. Nat Struct Mol Biol 22:11–19
Lant JT, Berg MD, Heinemann IU et al (2019) Pathways to disease from natural variations in human cytoplasmic tRNAs. J Biol Chem 294:5294–5308
Le Gras S, Keime C, Anthony A et al (2017) Altered enhancer transcription underlies Huntington’s disease striatal transcriptional signature. Sci Rep 7:42875
Lee A, Gilbert RM (2016) Epidemiology of Parkinson disease. Neurol Clin 34:955–965
Leidinger P, Backes C, Deutscher S et al (2013) A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol 14:R78
Leighton LJ, Bredy TW (2018) Functional interplay between small non-coding RNAs and RNA modification in the brain. Noncoding RNA 4:15
Lentini JM, Ramos J, Fu D (2018) Monitoring the 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) modification in eukaryotic tRNAs via the γ-toxin endonuclease. RNA 24:749–758
Lewis CJT, Pan T, Kalsotra A (2017) RNA modifications and structures cooperate to guide RNA-protein interactions. Nat Rev Mol Cell Biol 18:202–210
Li J, Liu C (2019) Coding or noncoding, the converging concepts of RNAs. Front Genet 10:496
Li S, Lv X, Zhai K et al (2016) MicroRNA-7 inhibits neuronal apoptosis in a cellular Parkinson’s disease model by targeting Bax and Sirt2. Am J Transl Res 8:993–1004
Li L, Liu H, Song H et al (2017) Let-7d microRNA attenuates 6-OHDA-induced injury by targeting caspase-3 in MN9D cells. J Mol Neurosci 63:403–411
Li D, Yang H, Ma J et al (2018a) MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson’s disease by targeting Nlrp3. Hum Cell 31:106–115
Li H, Ren Y, Mao K et al (2018b) FTO is involved in Alzheimer’s disease by targeting TSC1-mTOR-Tau signaling. Biochem Biophys Res Commun 498:234–239
Li L, Xu J, Wu M et al (2018c) Protective role of microRNA-221 in Parkinson’s disease. Bratisl Lek Listy 119:22–27
Li J, Chen W, Yi Y et al (2019) miR-219-5p inhibits tau phosphorylation by targeting TTBK1 and GSK-3β in Alzheimer’s disease. J Cell Biochem 120:9936–9946
Li D, Zhang J, Li X et al (2020a) Insights into lncRNAs in Alzheimer’s disease mechanisms. RNA Biol 1–11
Li Y, Fan H, Sun J et al (2020b) Circular RNA expression profile of Alzheimer’s disease and its clinical significance as biomarkers for the disease risk and progression. Int J Biochem Cell Biol 123:105747
Liguori M, Nuzziello N, Introna A et al (2018) Dysregulation of microRNAs and target genes networks in peripheral blood of patients with sporadic amyotrophic lateral sclerosis. Front Mol Neurosci 11:288
Liu Y, Lu Z (2018) Long non-coding RNA NEAT1 mediates the toxic of Parkinson’s disease induced by MPTP/MPP+ via regulation of gene expression. Clin Exp Pharmacol Physiol 45:841–848
Liu Z, Wang C, Wang X, Xu S (2015) Therapeutic effects of transplantation of As-MiR-937-expressing mesenchymal stem cells in murine model of Alzheimer’s disease. Cell Physiol Biochem 37:321–330
Liu S, Cui B, Dai Z et al (2016) Long non-coding RNA HOTAIR promotes Parkinson’s disease induced by MPTP through up-regulating the expression of LRRK2. Curr Neurovasc Res 13:115–120
Liu D, Tang H, Li X-Y et al (2017a) Targeting the HDAC2/HNF-4A/miR-101b/AMPK pathway rescues tauopathy and dendritic abnormalities in Alzheimer’s disease. Mol Ther 25:752–764
Liu W, Zhang Q, Zhang J et al (2017b) Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease. Cell Biosci 7:19
Liu H, Xu Y, Yao B et al (2020a) A novel N6-methyladenosine (m6A)-dependent fate decision for the lncRNA THOR. Cell Death Dis 11:613
Liu L, Wang Y, Wu J et al (2020b) N6-methyladenosine: a potential breakthrough for human cancer. Mol Ther Nucleic Acids 19:804–813
Liu Z, Chen X, Li Z et al (2020c) Role of RNA oxidation in neurodegenerative diseases. Int J Mol Sci 21:5022
Livneh I, Moshitch-Moshkovitz S, Amariglio N et al (2020) The m6A epitranscriptome: transcriptome plasticity in brain development and function. Nat Rev Neurosci 21:36–51
Lockhart J, Canfield J, Mong EF et al (2019) Nucleotide modification alters microRNA-dependent silencing of microRNA switches. Mol Ther Nucleic Acids 14:339–350
Long JM, Holtzman DM (2019) Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179:312–339
Long JM, Ray B, Lahiri DK (2014) MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects. J Biol Chem 289:5184–5198
Long JM, Maloney B, Rogers JT et al (2019) Novel upregulation of amyloid-β precursor protein (APP) by microRNA-346 via targeting of APP mRNA 5’-untranslated region: implications in Alzheimer’s disease. Mol Psychiat 24:345–363
Lontay B, Kiss A, Virág L et al (2020) How do post-translational modifications influence the pathomechanistic landscape of Huntington’s disease? A comprehensive review. Int J Mol Sci 21:4282
Lukiw WJ, Zhao Y, Cui JG (2008) An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem 283:31315–31322
Magini A, Polchi A, Tozzi A et al (2015) Abnormal cortical lysosomal β-hexosaminidase and β-galactosidase activity at post-synaptic sites during Alzheimer’s disease progression. Int J Biochem Cell Biol 58:62–70
Marsh J, Alifragis P (2018) Synaptic dysfunction in Alzheimer’s disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention. Neural Regen Res 13:616–623
Martino S (2015) Therapy for lysosomal storage disorders: a matter for stem cells. Int J Stem Cell Res Transplant 3:1–2
Martino S, Morena F, Barola C et al (2014) Proteomics and epigenetic mechanisms in stem cells. Current Proteomics 11:193–209
Mathis S, Goizet C, Soulages A et al (2019) Genetics of amyotrophic lateral sclerosis: a review. J Neurol Sci 399:217–226
Meng S, Zhou H, Feng Z et al (2019) Epigenetics in neurodevelopment: emerging role of circular RNA. Front Cell Neurosci 13:327
Migliore S, Jankovic J, Squitieri F (2019) Genetic counseling in Huntington’s disease: potential new challenges on horizon? Front Neurol 10:453
Millan MJ (2017) Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer’s disease: an integrative review. Prog Neurobiol 156:1–68
Modi PK, Jaiswal S, Sharma P (2016) Regulation of neuronal cell cycle and apoptosis by microRNA 34a. Mol Cell Biol 36:84–94
Mongelli A, Atlante S, Bachetti T et al (2020) Epigenetic signaling and RNA regulation in cardiovascular diseases. Int J Mol Sci 21:509
Morena F, Argentati C, Trotta R et al (2017) A comparison of lysosomal enzymes expression levels in peripheral blood of mild- and severe-Alzheimer’s disease and MCI patients: implications for regenerative medicine approaches. Int J Mol Sci 18:1806
Morena F, Argentati C, Bazzucchi M et al (2018) Above the epitranscriptome: RNA modifications and stem cell identity. Genes (Basel) 9:329
Morena F, Oikonomou V, Argentati C et al (2019) Integrated computational analysis highlights unique miRNA signatures in the subventricular zone and striatum of GM2 gangliosidosis animal models. Int J Mol Sci 20:3179
Morena F, Argentati C, Acquati S et al (2020) Toward reference intervals of ARSA activity in the cerebrospinal fluid: implication for the clinical practice of metachromatic leukodystrophy. J Appl Lab Med. https://doi.org/10.1093/jalm/jfaa108
Nalls MA, Blauwendraat C, Vallerga CL et al (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson’s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18:1091–1102
Nan Y, Han L, Zhang A et al (2010) MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 1359:14–21
Neueder A (2019) RNA-mediated disease mechanisms in neurodegenerative disorders. J Mol Biol 431:1780–1791
Neueder A, Bates GP (2018) RNA related pathology in Huntington’s disease. Adv Exp Med Biol 1049:85–101
Nishimoto Y, Nakagawa S, Hirose T et al (2013) The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis. Mol Brain 6:31
Nourse J, Spada S, Danckwardt S (2020) Emerging roles of RNA 3’-end cleavage and polyadenylation in pathogenesis, diagnosis and therapy of human disorders. Biomolecules 10:915
Noyce AJ, Bestwick JP, Silveira-Moriyama L et al (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72:893–901
Oerum S, Dégut C, Barraud P et al (2017) m1A post-transcriptional modification in tRNAs. Biomolecules 7:20
Orlacchio A, Bernardi G, Orlacchio A et al (2007) RNA interference as a tool for Alzheimer’s disease therapy. Mini Rev Med Chem 7:1166–1176
Orlacchio A, Bernardi G, Orlacchio A et al (2008) Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS. Exp Opin Therap Patents 18:1161–1174
Orozco-Díaz R, Sánchez-Álvarez A, Hernández-Hernández JM et al (2019) The interaction between RE1-silencing transcription factor (REST) and heat shock protein 90 as new therapeutic target against Huntington’s disease. PLoS One 14:e0220393
Oskarsson B, Gendron TF, Staff NP (2018) Amyotrophic lateral sclerosis: an update for 2018. Mayo Clin Proc 93:1617–1628
Ozsait B, Komurcu-Bayrak E, Levula M et al (2010) Niemann-Pick type C fibroblasts have a distinct microRNA profile related to lipid metabolism and certain cellular components. Biochem Biophys Res Commun 403:316–321
Pan T (2018) Modifications and functional genomics of human transfer RNA. Cell Res 28:395–404
Parisi C, Napoli G, Amadio S et al (2016) MicroRNA-125b regulates microglia activation and motor neuron death in ALS. Cell Death Differ 23:531–541
Penke B, Szűcs M, Bogár F (2020) Oligomerization and conformational change turn monomeric β-amyloid and tau proteins toxic: their role in Alzheimer’s pathogenesis. Molecules 25:1659
Platt FM, Boland B, van der Spoel AC (2012) The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction. J Cell Biol 199:723–734
Postuma RB, Berg D, Stern M et al (2015) MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord 30:1591–1601
Qin L, Min S, Shu L et al (2020) Genetic analysis of N6-methyladenosine modification genes in Parkinson’s disease. Neurobiol Aging 93:143.e9–143.e13
Quan Z, Zheng D, Qing H (2017) Regulatory roles of long non-coding RNAs in the central nervous system and associated neurodegenerative diseases. Front Cell Neurosci 11:175
Queiroz MT, Pereira VG, do Nascimento CC et al (2016) The underexploited role of non-coding RNAs in lysosomal storage diseases. Front Endocrinol (Lausanne) 7:133
Quinlan S, Kenny A, Medina M et al (2017) MicroRNAs in neurodegenerative diseases. Int Rev Cell Mol Biol 334:309–343
Quintavalle C, Garofalo M, Zanca C et al (2012) miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ. Oncogene 31:858–868
Rafels-Ybern À, Torres AG, Grau-Bove X et al (2018) Codon adaptation to tRNAs with Inosine modification at position 34 is widespread among eukaryotes and present in two bacterial phyla. RNA Biol 15:500–507
Ravnik-Glavač M, Glavač D (2020) Circulating RNAs as potential biomarkers in amyotrophic lateral sclerosis. Int J Mol Sci 21:1714
Ren J, Yang Y, Xue J et al (2018) Long noncoding RNA SNHG7 promotes the progression and growth of glioblastoma via inhibition of miR-5095. Biochem Biophys Res Commun 496:712–718
Rinchetti P, Rizzuti M, Faravelli I et al (2018) MicroRNA metabolism and dysregulation in amyotrophic lateral sclerosis. Mol Neurobiol 55:2617–2630
Riva P, Ratti A, Venturin M (2016) The long non-coding RNAs in neurodegenerative diseases: novel mechanisms of pathogenesis. Curr Alzheimer Res 13:1219–1231
Rodriguez CM, Todd PK (2019) New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiol Dis 130:104515
Romano G, Veneziano D, Nigita G et al (2018) RNA methylation in ncRNA: classes, detection, and molecular associations. Front Genet 9:243
Romo L, Ashar-Patel A, Pfister E et al (2017) Alterations in mRNA 3’ UTR isoform abundance accompany gene expression changes in human Huntington’s disease brains. Cell Rep 20:3057–3070
Rong D, Sun H, Li Z et al (2017) An emerging function of circRNA-miRNAs-mRNA axis in human diseases. Oncotarget 8:73271–73281
Roundtree IA, Evans ME, Pan T et al (2017) Dynamic RNA modifications in gene expression regulation. Cell 169:1187–1200
Rudich P, Watkins S, Lamitina T (2020) PolyQ-independent toxicity associated with novel translational products from CAG repeat expansions. PLoS One 15:e0227464
Salvatori B, Biscarini S, Morlando M (2020) Non-coding RNAs in nervous system development and disease. Front Cell Dev Biol 8:273
Santa-Maria I, Alaniz ME, Renwick N et al (2015) Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125:681–686
Sarkar S, Jun S, Rellick S et al (2016) Expression of microRNA-34a in Alzheimer’s disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity. Brain Res 1646:139–151
Saudou F, Humbert S (2016) The biology of huntingtin. Neuron 89:910–926
Schymick JC, Scholz SW, Fung H-C et al (2007) Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol 6:322–328
Scoles DR, Minikel EV, Pulst SM (2019) Antisense oligonucleotides: a primer. Neurol Genet 5:e323
Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 8:595–608
Sergiev PV, Aleksashin NA, Chugunova AA et al (2018) Structural and evolutionary insights into ribosomal RNA methylation. Nat Chem Biol 14:226–235
Shafik A, Schumann U, Evers M et al (2016) The emerging epitranscriptomics of long noncoding RNAs. Biochim Biophys Acta 1859:59–70
Shannon KM (2020) Recent advances in the treatment of Huntington’s disease: targeting DNA and RNA. CNS Drugs 34:219–228
Shao W, Peng D, Wang X (2017) Genetics of Alzheimer’s disease: from pathogenesis to clinical usage. J Clin Neurosci 45:1–8
Shen J, Hodges TR, Song R et al (2018) Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma. Mol Carcinog 57:137–141
Shi J, Wang Y-J, Sun C-R et al (2017) Long noncoding RNA lncHERG promotes cell proliferation, migration and invasion in glioblastoma. Oncotarget 8:108031–108041
Shu M, Zheng X, Wu S et al (2011) Targeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cells. Mol Cancer 10:59
Sierksma A, Lu A, Salta E et al (2018) Deregulation of neuronal miRNAs induced by amyloid-β or TAU pathology. Mol Neurodegener 13:54
Sinha M, Ghose J, Bhattarcharyya NP (2011) Micro RNA -214,-150,-146a and-125b target huntingtin gene. RNA Biol 8:1005–1021
Smith AV, Tabrizi SJ (2020) Therapeutic antisense targeting of huntingtin. DNA Cell Biol 39:154–158
Smith PY, Hernandez-Rapp J, Jolivette F et al (2015) miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 24:6721–6735
Song J, Yi C (2019) Reading chemical modifications in the transcriptome. J Mol Biol. S0022-2836(19):30598–30594
Sun W, Samimi H, Gamez M et al (2018) Pathogenic tau-induced piRNA depletion promotes neuronal death through transposable element dysregulation in neurodegenerative tauopathies. Nat Neurosci 21:1038–1048
Swarbrick S, Wragg N, Ghosh S et al (2019) Systematic Review of miRNA as Biomarkers in Alzheimer’s disease. Mol Neurobiol 56:6156–6167
Tabrizi SJ, Flower MD, Ross CA et al (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16:529–546
Tang Y, Bao JS, Su JH et al (2017) MicroRNA-139 modulates Alzheimer’s-associated pathogenesis in SAMP8 mice by targeting cannabinoid receptor type 2. Genet Mol Res 16(1). https://doi.org/10.4238/gmr16019166
Torres AG, Batlle E, Ribas de Pouplana L (2014) Role of tRNA modifications in human diseases. Trends Mol Med 20:306–314
Trixl L, Lusser A (2019) The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark. Wiley Interdiscip Rev RNA 10:e1510
Urbanelli L, Emiliani C, Massini C et al (2008) Cathepsin D expression is decreased in Alzheimer’s disease fibroblasts. Neurobiol Aging 29:12–22
Urbanelli L, Magini A, Polchi A et al (2011) Recent developments in therapeutic approaches for lysosomal storage diseases. Recent Pat CNS Drug Discov 6:1–19
Ursu A, Vézina-Dawod S, Disney MD (2019) Methods to identify and optimize small molecules interacting with RNA (SMIRNAs). Drug Discov Today 24:2002–2016
Valdez G, Heyer MP, Feng G et al (2014) The role of muscle microRNAs in repairing the neuromuscular junction. PLoS One 9:e93140
van den Berg MMJ, Krauskopf J, Ramaekers JG et al (2020) Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol 185:101732
van der Lee SJ, Wolters FJ, Ikram MK et al (2018) The effect of APOE and other common genetic variants on the onset of Alzheimer’s disease and dementia: a community-based cohort study. Lancet Neurol 17:434–444
van Es MA, Hardiman O, Chio A et al (2017) Amyotrophic lateral sclerosis. Lancet 390:2084–2098
Vandivier LE, Gregory BD (2017) Reading the epitranscriptome: new techniques and perspectives. Enzymes 41:269–298
Varghese S, Cotter M, Chevot F et al (2017) In vivo modification of tRNA with an artificial nucleobase leads to full disease remission in an animal model of multiple sclerosis. Nucleic Acids Res 45:2029–2039
Vassallo I, Zinn P, Lai M et al (2016) WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 35:12–21
Vieira AS, Dogini DB, Lopes-Cendes I (2018) Role of non-coding RNAs in non-aging-related neurological disorders. Braz J Med Biol Res 51:e7566
Vilardo E, Barbato C, Ciotti M et al (2010) MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons. J Biol Chem 285:18344–18351
Villar-Menéndez I, Porta S, Buira SP et al (2014) Increased striatal adenosine A2A receptor levels is an early event in Parkinson’s disease-related pathology and it is potentially regulated by miR-34b. Neurobiol Dis 69:206–214
Visvanathan A, Patil V, Arora A et al (2018) Essential role of METTL3-mediated m6A modification in glioma stem-like cells maintenance and radioresistance. Oncogene 37:522–533
Vrabec K, Boštjančič E, Koritnik B et al (2018) Differential expression of several miRNAs and the host genes AATK and DNM2 in leukocytes of sporadic ALS patients. Front Mol Neurosci 11:106
Wan G, Zhou W, Hu Y et al (2016) Transcriptional regulation of lncRNA genes by histone modification in Alzheimer’s disease. Biomed Res Int 2016:3164238
Wan Y-W, Al-Ouran R, Mangleburg CG et al (2020) Meta-analysis of the Alzheimer’s disease human brain transcriptome and functional dissection in mouse models. Cell Rep 32:107908
Wang Z-H, Zhang J-L, Duan Y-L et al (2015) MicroRNA-214 participates in the neuroprotective effect of Resveratrol via inhibiting α-synuclein expression in MPTP-induced Parkinson’s disease mouse. Biomed Pharmacother 74:252–256
Wang D-Q, Fu P, Yao C et al (2018a) Long non-coding RNAs, novel culprits, or bodyguards in neurodegenerative diseases. Mol Ther Nucleic Acids 10:269–276
Wang Z, Xu P, Chen B et al (2018b) Identifying circRNA-associated-ceRNA networks in the hippocampus of Aβ1-42-induced Alzheimer’s disease-like rats using microarray analysis. Aging (Albany NY) 10:775–788
Wei C-W, Luo T, Zou S-S et al (2018) The role of long noncoding RNAs in central nervous system and neurodegenerative diseases. Front Behav Neurosci 12:175
Wei W, Wang Z-Y, Ma L-N et al (2020) MicroRNAs in Alzheimer’s disease: function and potential applications as diagnostic biomarkers. Front Mol Neurosci 13:160
Wen Y, Yu WH, Maloney B et al (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57:680–690
Wu Y-Y, Kuo H-C (2020) Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases. J Biomed Sci 27:49
Wu P, Zuo X, Deng H et al (2013) Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases. Brain Res Bull 97:69–80
Wu D-M, Wen X, Wang Y-J et al (2018) Effect of microRNA-186 on oxidative stress injury of neuron by targeting interleukin 2 through the Janus kinase-signal transducer and activator of transcription pathway in a rat model of Alzheimer’s disease. J Cell Physiol 233:9488–9502
Wu D-M, Wang S, Wen X et al (2019) Suppression of microRNA-342-3p increases glutamate transporters and prevents dopaminergic neuron loss through activating the Wnt signaling pathway via p21-activated kinase 1 in mice with Parkinson’s disease. J Cell Physiol 234:9033–9044
Xie L, Mao M, Xiong K et al (2017) Circular RNAs: a novel player in development and disease of the central nervous system. Front Cell Neurosci 11:354
Xing H, Guo S, Zhang Y et al (2016) Upregulation of microRNA-206 enhances lipopolysaccharide-induced inflammation and release of amyloid-β by targeting insulin-like growth factor 1 in microglia. Mol Med Rep 14:1357–1364
Xiong X, Li X, Yi C (2018) N1-methyladenosine methylome in messenger RNA and non-coding RNA. Curr Opin Chem Biol 45:179–186
Xu X, Wang Y, Liang H (2018) The role of A-to-I RNA editing in cancer development. Curr Opin Genet Dev 48:51–56
Xylaki M, Atzler B, Outeiro TF (2019) Epigenetics of the synapse in neurodegeneration. Curr Neurol Neurosci Rep 19:72
Yan C, Wan R, Shi Y (2019) Molecular mechanisms of pre-mRNA splicing through structural biology of the spliceosome. Cold Spring Harb Perspect Biol 11:a032409
Yang CH, Yue J, Pfeffer SR et al (2014) MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating insulin-like growth factor-binding protein-3 (IGFBP3). J Biol Chem 289:25079–25087
Yang G, Song Y, Zhou X et al (2015) MicroRNA-29c targets β-site amyloid precursor protein-cleaving enzyme 1 and has a neuroprotective role in vitro and in vivo. Mol Med Rep 12:3081–3088
Yang CP, Zhang ZH, Zhang LH et al (2016) Neuroprotective role of microRNA-22 in a 6-hydroxydopamine-induced cell model of Parkinson’s disease via regulation of its target gene TRPM7. J Mol Neurosci 60:445–452
Yang X, Liu M, Li M et al (2020) Epigenetic modulations of noncoding RNA: a novel dimension of Cancer biology. Mol Cancer 19:64
Yeasmin F, Yada T, Akimitsu N (2018) Micropeptides encoded in transcripts previously identified as long noncoding RNAs: a new chapter in transcriptomics and proteomics. Front Genet 9:144
Zendjabil M (2018) Circulating microRNAs as novel biomarkers of Alzheimer’s disease. Clin Chim Acta 484:99–104
Zetterberg H, Burnham SC (2019) Blood-based molecular biomarkers for Alzheimer’s disease. Mol Brain 12:26
Zhang Z, Cheng Y (2014) miR-16-1 promotes the aberrant α-synuclein accumulation in Parkinson disease via targeting heat shock protein 70. Sci World J 2014:938348
Zhang C, Jia G (2018) Reversible RNA modification N1-methyladenosine (m1A) in mRNA and tRNA. Genomics Proteomics Bioinf 16:155–161
Zhang C-Z, Zhang J-X, Zhang A-L et al (2010) MiR-221 and miR-222 target PUMA to induce cell survival in glioblastoma. Mol Cancer 9:229
Zhang J, Hu M, Teng Z et al (2014) Synaptic and cognitive improvements by inhibition of 2-AG metabolism are through upregulation of microRNA-188-3p in a mouse model of Alzheimer’s disease. J Neurosci 34:14919–14933
Zhang B, Chen C-F, Wang A-H et al (2015a) MiR-16 regulates cell death in Alzheimer’s disease by targeting amyloid precursor protein. Eur Rev Med Pharmacol Sci 19:4020–4027
Zhang Y, Han D, Wei W et al (2015b) MiR-218 inhibited growth and metabolism of human glioblastoma cells by directly targeting E2F2. Cell Mol Neurobiol 35:1165–1173
Zhang B, Wang L-L, Ren R-J et al (2016) MicroRNA-146a represses LRP2 translation and leads to cell apoptosis in Alzheimer’s disease. FEBS Lett 590:2190–2200
Zhang S, Zhu D, Li H et al (2017) Characterization of circRNA-associated-ceRNA networks in a senescence-accelerated mouse prone 8 brain. Mol Ther 25:2053–2061
Zhang Y-H, Bai S-F, Yan J-Q (2019) Blood circulating miRNAs as biomarkers of Alzheimer’s disease: a systematic review and meta-analysis. Biomark Med 13:1045–1054
Zhang Y, Xia Q, Lin J (2020) LncRNA H19 attenuates apoptosis in MPTP-Induced Parkinson’s disease through regulating miR-585-3p/PIK3R3. Neurochem Res 45:1700–1710
Zhao Z-B, Wu L, Xiong R et al (2014) MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer’s disease. Neuroscience 275:232–237
Zhao Y, Alexandrov PN, Jaber V et al (2016) Deficiency in the ubiquitin conjugating enzyme UBE2A in Alzheimer’s disease (AD) is linked to deficits in a natural circular miRNA-7 sponge (circRNA; ciRS-7). Genes (Basel) 7:116
Zhao Y, Dunker W, Yu Y-T et al (2018) The role of noncoding RNA pseudouridylation in nuclear gene expression events. Front Bioeng Biotechnol 6:8
Zhao M-Y, Wang G-Q, Wang N-N et al (2019) The long-non-coding RNA NEAT1 is a novel target for Alzheimer’s disease progression via miR-124/BACE1 axis. Neurol Res 41:489–497
Zhou C, Molinie B, Daneshvar K et al (2017) Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs. Cell Rep 20:2262–2276
Zhou Y, Wang Z-F, Li W et al (2018) Protective effects of microRNA-330 on amyloid β-protein production, oxidative stress, and mitochondrial dysfunction in Alzheimer’s disease by targeting VAV1 via the MAPK signaling pathway. J Cell Biochem 119:5437–5448
Zhou Y, Deng J, Chu X et al (2019) Role of post-transcriptional control of calpain by miR-124-3p in the development of Alzheimer’s disease. J Alzheimers Dis 67:571–581
Zhu Z-M, Huo F-C, Pei D-S (2020) Function and evolution of RNA N6-methyladenosine modification. Int J Biol Sci 16:1929–1940
Zimmer-Bensch G (2019) Emerging roles of long non-coding RNAs as drivers of brain evolution. Cells 8:1399
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Calzoni, E. et al. (2021). RNA Modifications in Neurodegenerations. In: Jurga, S., Barciszewski, J. (eds) Epitranscriptomics. RNA Technologies, vol 12. Springer, Cham. https://doi.org/10.1007/978-3-030-71612-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-71612-7_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71611-0
Online ISBN: 978-3-030-71612-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)